It’s Official! Vodafone Group plc, GlaxoSmithKline plc & Imperial Tobacco Group PLC Are The Best Income Stocks In The World

Vodafone Group plc (LON: VOD), GlaxoSmithKline plc (LON: GSK) and Imperial Tobacco Group PLC (LON: IMT) offer the best dividend yields around.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every year, the top City analysts produce a chart outlining the best dividend yields on offer in the developed markets consumer goods sector.

This year, Vodafone (LSE: VOD) and GlaxoSmithKline (LSE: GSK) topped the list, Philip Morris — owner of the infamous Marlboro brand of cigarettes — came in third, and Imperial Tobacco (LSE: IMT) fourth, making these three UK-listed dividend champions some of the world’s best income stocks.

Stable income 

Vodafone, Glaxo, Philip Morris and Imperial all top the list of the best income stocks because they have the most stable income streams.

Indeed, other companies like BHP Billiton may offer more attractive dividend yields at present, but due to the cyclical nature of BHP’s business, the company could be forced to cut the dividend at a moment’s notice — something Santander and Centrica shareholders have recently had to grapple with.

Not only do these companies have relatively safe dividend payouts, they also have a history of looking after their shareholders. Vodafone, for example, has returned the vast majority of the cash it has generated from operations to shareholders over the years.

Additionally, special dividends were issued when the company received dividend payments from its US joint venture with Verizon. The company also returned half of the cash received from the sale of the joint venture to investors. 

Vodafone’s shares currently support a dividend yield of 4.7%, although the dividend payout of 11.5p per share isn’t wholly covered by earnings per share of 6.3p. Still, City analysts expect the company’s dividend payout to increase steadily in line with inflation over the next three years. 

Similarly, Glaxo has a history of returning the majority of its free cash flow to investors. In particular, the company’s dividend yield has averaged 5.2% over the past five years, excluding the benefit to shareholders of any stock buybacks undertaken. This year the group is planning to return an additional £4bn to shareholders following the completion of the asset swap with Swiss pharma giant Novartis

With around 5bn shares outstanding, a cash return of £4bn is worth around 80p per share. In other words, Glaxo’s investors are set to receive a special dividend of 80p per share this year — excluding the company’s regular dividend payout of 80p per annum.

Finally, at present levels Imperial supports a dividend yield of 4.1%. The payout is covered one-and-a-half times by earnings per share.  

Unfortunately, Imperial’s dividend yield is the lowest of the three companies in this article.

However, Imperial’s dividend yield is set to grow rapidly over the next three years. In fact, the payout is set to grow at a rate of around 10% per annum until 2017. Glaxo’s payout is expected to remain unchanged for the next year or two, while Vodafone’s is only expected to grow in line with inflation.

Imperial’s payout growth means that the company is set to yield 4.6% this year, 5.1% during 2016 and 5.6% during 2017. That’s growth worth paying for. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of GlaxoSmithKline and Imperial Tobacco Group. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 of my top FTSE 250 stocks to consider buying before April

Buying undervalued UK shares can be a great way to generate long-term wealth. Here, Royston Wild reveals a handful on…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »